BRTX stockholders elect directors, approve share increase, ratify auditor at annual meeting

BioRestorative Therapies, Inc.

Class III directors Lance Alstodt and Patrick F. Williams elected with 864,671 and 662,099 votes for, respectively.
Amendment to 2021 Stock Incentive Plan approved: 571,623 for, 276,247 against, 1,907,427 broker non-votes.
Marcum LLP ratified as independent auditor for FY 2023: 2,751,541 for, 15,525 against.
Plan amendment increases authorized shares from 2.5M to 3.85M.
All proposals passed despite significant broker non-votes on director election and plan.

item 5.07

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BioRestorative Therapies, Inc. shareholders approved Election of Class III Directors at the 2023-09-13 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-09-13

Exact text from the filing

Number of Shares For Withheld Broker Non-Votes Lance Alstodt 864,671 6,038 1,907,427 Patrick F. Williams 662,099 208,610 1,907,427

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BioRestorative Therapies, Inc. shareholders approved Ratification of the selection of Marcum LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-09-13 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-09-13

Exact text from the filing

For 2,751,541 Against 15,525 Abstentions 11,070

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BioRestorative Therapies, Inc. shareholders approved Approval of amendment to the Company’s 2021 Stock Incentive Plan to increase authorized shares from 2,500,000 to 3,850,000 at the 2023-09-13 meeting.

Proposal: equity plan
Outcome: passed
Meeting: 2023-09-13

Exact text from the filing

Against 276,247 Abstentions 22,839

View on SEC.gov

63 shareholder votes filed in the last 30 days. Browse all shareholder votes →

BioRestorative Therapies, Inc. filing history →

Source: SEC EDGAR

accession 0001021771-23-000094

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.